Collection Symposium Series 1999, 3, 1-5
https://doi.org/10.1135/css199903001
Published online 2016-03-16 22:53:17

Polypeptide laboratories – Development and production of peptides as drugs

Martin Flegel

Individual author index pages


Other CCCC articles of these authors

  • Martin Flegel
    Peptide production and connected paperwork
    Symposium Series 2001, Vol. 4, pp. 1–6 [Abstract]
    Published online 2016-04-21 09:02:30
  • Martin Flegel
    Manufacturing of peptides as bulk pharmaceutical chemicals
    Symposium Series 2003, Vol. 6, pp. 20–25 [Abstract]
    Published online 2016-01-17 20:54:41
  • Petra Sázelová, Václav Kašička, Veronika Šolínová, Martin Flegel and Tomislav Barth
    Application of capillary zone electrophoresis and isotachophoresis to the evaluation of purity degree and counter-ions content in lecirelin preparations
    Symposium Series 2007, Vol. 9, pp. 86–89 [Abstract]
    Published online 2015-11-06 11:54:38
  • Věra Klenerová, Martin Flegel and Sixtus Hynie
    Selective oxytocin antagonist and its use for antagonizing oxytocin effects tested by behavioral studies in the open field
    Symposium Series 2009, Vol. 11, pp. 64–68 [Abstract]
    Published online 2015-08-26 09:41:55
  • Martin Flegel, Zuzana Flegelová, Petr Maloň, Věra Klenerová and Sixtus Hynie
    Fmoc deprotection by tert-butylamine and its comparison in solution and solid phase synthesis
    Symposium Series 2011, Vol. 13, pp. 41–44 [Abstract]
    Published online 2015-07-15 10:12:01
  • Jaroslav Vičar, Martin Flegel, Linda Hauzerová, Tzezengijn Dash, Karel Hauzer and Tomislav Barth
    Synthesis and biologic properties of an enkephalin analogue, a model substrate for enzymic conversion
    1985, Vol. 50, Issue 9, pp. 2084–2088 [Abstract]
  • Jaroslav Vičar, Linda Servítová, Martin Flegel, Karel Hauzer and Tomislav Barth
    Preparation and properties of three analogues of [5-leucine]enkephalin, substrates for enzyme conversion studies
    1985, Vol. 50, Issue 6, pp. 1329–1334 [Abstract]
  • Tomislav Barth, Pavel Hrbas, Jana Škopková, Hans Vilhardt, Martin Flegel and Karel Jošt
    The effect of some structural changes in the molecule of vasopressin on the duration of antidiuretic action
    1984, Vol. 49, Issue 1, pp. 137–140 [Abstract]
  • Milan Zaoral, František Brtník, Martin Flegel, Tomislav Barth and Alena Machová
    [1-β-Mercaptopropionic acid, 8-norarginine]vasopressin and [1-β-mercaptopropionic acid, 8-D-norarginine]vasopressin. Two analogs with strong biological effects
    1979, Vol. 44, Issue 4, pp. 1179–1186 [Abstract]
  • Milan Zaoral, Martin Flegel, Tomislav Barth and Alena Machová
    Purification of ten-grammes amounts of [1-β-mercaptopropionic acid, 8-D-arginine]vasopressin (DDAVP) on a continuous free-flow electrophoresis. Chemical and pharmacological data of DDAVP and by-products
    1978, Vol. 43, Issue 2, pp. 511–522 [Abstract]